Long-term follow-up of the SBG 9401 study comparing tailored FEC-based therapy versus marrow-supported high-dose therapy

N Wilking; E Lidbrink; T Wiklund; B Erikstein; H Lindman; P Malmstrom; P Kellokumpu-Lehtinen; NO Bengtsson; G Soderlund; G Anker; E Wist; S Ottosson; E Salminen; P Ljungman; H Holte; J Nilsson; C Blomqvist; J. Bergh

doi:10.1093/annonc/mdl488

Long-term follow-up of the SBG 9401 study comparing tailored FEC-based therapy versus marrow-supported high-dose therapy

N Wilking, E Lidbrink, T Wiklund, B Erikstein, H Lindman, P Malmstrom, P Kellokumpu-Lehtinen, NO Bengtsson, G Soderlund, G Anker, E Wist, S Ottosson, E Salminen, P Ljungman, H Holte, J Nilsson, C Blomqvist, J. Bergh

Syövänhoidon vastuualue

Tutkimustuotos: Article › Scientific › vertaisarvioitu

32 Sitaatiot (Scopus)

Alkuperäiskieli	Englanti
Sivut	694-700
Julkaisu	Ann Oncol.
Vuosikerta	18
Numero	4
DOI - pysyväislinkit	https://doi.org/10.1093/annonc/mdl488
Tila	Julkaistu - 2007
OKM-julkaisutyyppi	A1 Alkuperäisartikkeli

Pääsy asiakirjaan

10.1093/annonc/mdl488

Siteeraa tätä

Wilking, N., Lidbrink, E., Wiklund, T., Erikstein, B., Lindman, H., Malmstrom, P., Kellokumpu-Lehtinen, P., Bengtsson, NO., Soderlund, G., Anker, G., Wist, E., Ottosson, S., Salminen, E., Ljungman, P., Holte, H., Nilsson, J., Blomqvist, C., & Bergh, J. (2007). Long-term follow-up of the SBG 9401 study comparing tailored FEC-based therapy versus marrow-supported high-dose therapy. Ann Oncol., 18(4), 694-700. https://doi.org/10.1093/annonc/mdl488

Wilking, N ; Lidbrink, E ; Wiklund, T ; Erikstein, B ; Lindman, H ; Malmstrom, P ; Kellokumpu-Lehtinen, P ; Bengtsson, NO ; Soderlund, G ; Anker, G ; Wist, E ; Ottosson, S ; Salminen, E ; Ljungman, P ; Holte, H ; Nilsson, J ; Blomqvist, C ; Bergh, J. / Long-term follow-up of the SBG 9401 study comparing tailored FEC-based therapy versus marrow-supported high-dose therapy. Julkaisussa: Ann Oncol. 2007 ; Vuosikerta 18, Nro 4. Sivut 694-700.

@article{665edb2c501a4e25abaf49f44ae0aa4e,

title = "Long-term follow-up of the SBG 9401 study comparing tailored FEC-based therapy versus marrow-supported high-dose therapy",

author = "N Wilking and E Lidbrink and T Wiklund and B Erikstein and H Lindman and P Malmstrom and P Kellokumpu-Lehtinen and NO Bengtsson and G Soderlund and G Anker and E Wist and S Ottosson and E Salminen and P Ljungman and H Holte and J Nilsson and C Blomqvist and J. Bergh",

year = "2007",

doi = "10.1093/annonc/mdl488",

language = "English",

volume = "18",

pages = "694--700",

number = "4",

}

Wilking, N, Lidbrink, E, Wiklund, T, Erikstein, B, Lindman, H, Malmstrom, P, Kellokumpu-Lehtinen, P, Bengtsson, NO, Soderlund, G, Anker, G, Wist, E, Ottosson, S, Salminen, E, Ljungman, P, Holte, H, Nilsson, J, Blomqvist, C & Bergh, J 2007, 'Long-term follow-up of the SBG 9401 study comparing tailored FEC-based therapy versus marrow-supported high-dose therapy', Ann Oncol., Vuosikerta 18, Nro 4, Sivut 694-700. https://doi.org/10.1093/annonc/mdl488

Long-term follow-up of the SBG 9401 study comparing tailored FEC-based therapy versus marrow-supported high-dose therapy. / Wilking, N; Lidbrink, E; Wiklund, T; Erikstein, B; Lindman, H; Malmstrom, P; Kellokumpu-Lehtinen, P; Bengtsson, NO; Soderlund, G; Anker, G; Wist, E; Ottosson, S; Salminen, E; Ljungman, P; Holte, H; Nilsson, J; Blomqvist, C; Bergh, J.

julkaisussa: Ann Oncol., Vuosikerta 18, Nro 4, 2007, s. 694-700.

Tutkimustuotos: Article › Scientific › vertaisarvioitu

TY - JOUR

T1 - Long-term follow-up of the SBG 9401 study comparing tailored FEC-based therapy versus marrow-supported high-dose therapy

AU - Wilking, N

AU - Lidbrink, E

AU - Wiklund, T

AU - Erikstein, B

AU - Lindman, H

AU - Malmstrom, P

AU - Kellokumpu-Lehtinen, P

AU - Bengtsson, NO

AU - Soderlund, G

AU - Anker, G

AU - Wist, E

AU - Ottosson, S

AU - Salminen, E

AU - Ljungman, P

AU - Holte, H

AU - Nilsson, J

AU - Blomqvist, C

AU - Bergh, J.

PY - 2007

Y1 - 2007

U2 - 10.1093/annonc/mdl488

DO - 10.1093/annonc/mdl488

M3 - Article

VL - 18

SP - 694

EP - 700

IS - 4

ER -